Arkansas Children's Hospital is a pediatric hospital with a Level I trauma center in Little Rock, Arkansas. It is among the largest in the United States, serving infants, children, teens, and young adults from birth to age 21.

There are 336 beds in Arkansas Children's Hospital.

During the past decade, Arkansas Children's Hospital conducted 222 clinical trials. In the 10-year time frame, 222 clinical trials started and 112 clinical trials were completed, i.e. on average, 50.5% percent of trials that started reached the finish line to date. In the past 5 years, 99 clinical trials started and 74 clinical trials were completed. i.e. 74.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arkansas Children's Hospital" #1 sponsor was "Children's Oncology Group" with 70 trials, followed by "National Cancer Institute (NCI)" with 48 trials sponsored, "Arkansas Children's Hospital Research Institute" with 32 trials sponsored, "University of Arkansas" with 15 trials sponsored and "Aimmune Therapeutics, Inc." with 15 trials sponsored. Other sponsors include 204 different institutions and companies that sponsored additional 125 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arkansas Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 70 trials as a collaborator, "Arkansas Children's Hospital Research Institute" with 15 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 10 trials as a collaborator, "Seattle Children's Hospital" with 9 trials as a collaborator and "Baylor College of Medicine" with 7 trials as a collaborator. Other collaborators include 310 different institutions and companies that were collaborators in the rest 199 trials.

According to Clinical.Site data, the most researched conditions in "Arkansas Children's Hospital" are "Recurrent Neuroblastoma" (20 trials), "Peanut Allergy" (15 trials), "Recurrent Osteosarcoma" (15 trials), "Refractory Neuroblastoma" (15 trials) and "Refractory Non-Hodgkin Lymphoma" (14 trials). Many other conditions were trialed in "Arkansas Children's Hospital" in a lesser frequency.

Most popular intervention types in "Arkansas Children's Hospital" are "Drug" (236 trials), "Other" (113 trials), "Biological" (70 trials), "Procedure" (52 trials) and "Radiation" (34 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (53 trials), "Cyclophosphamide" (38 trials), "Vincristine Sulfate" (34 trials), "Placebo" (29 trials) and "Etoposide" (26 trials). Other intervention names were less common.

The vast majority of trials in "Arkansas Children's Hospital" are 363 trials for "All" genders, 16 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are 185 active trials in "Arkansas Children's Hospital". 4 are not yet recruiting, 97 are recruiting, 78 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 152 completed trials in Arkansas Children's Hospital, 3 suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Arkansas Children's Hospital, 40 "Phase 1" clinical trials were conducted, 111 "Phase 2" clinical trials and 129 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 42 trials that are defined as “Not Applicable".

Arkansas Children's Hospital has several departments that took part in Clinical trials: "Arkansas Children's Hospital Research Institute" - 60 trials, "Arkansas Children's Hospital - Infectious Diseases" - 6 trials, "Arkansas Children's Hospital Research Pharmacy" - 2 trials